On the recordJuly 22, 2013
it is entirely proper to put the burden on the drug companies to demonstrate that actually these have a pro-competitive, not anti-competitive impact.
Source
congress.govEditor's note · Context
Klobuchar emphasizes the need for drug companies to prove their practices benefit consumers.
Share & report
More from Amy Klobuchar
Jun 7, 2025
So when you look at what's happening here, Trump is doing some really bad things to people, right?
May 19, 2025
Instead of working with Democrats to lower costs from President Trump’s across-the-board tariffs, House Republicans have decided to pull the rug out from under families by cutting the SNAP benefits that 42 million Americans rely on to put…
Other voices in this conversation
